DepoMed (DEPO) Sell-Off an 'Over-Reaction', Roth Capital Says; PT to $28.50

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. SKYD
6. BBIO
7. CRBU
8. FIGR
9. OPCH
10. NEOG

Go back to DepoMed (DEPO) Sell-Off an 'Over-Reaction', Roth Capital Says; PT to $28.50

Janney Capital Upgrades DepoMed Inc (DEPO) to Buy

May 12, 2015 12:23 PM EDT

Janney Capital upgraded DepoMed Inc (NASDAQ: DEPO) from Neutral to Buy with a price target of $25.50.

Analyst Chiara Russon commented, "With DEPO opening down ~18.5% this morning, this puts our $25.50 FV squarely in the 20% upside, enough to give the name a Buy rating.... More

DepoMed (DEPO) Misses Q1 EPS by 14c; Guides FY15 Sales Above Views

May 11, 2015 4:15 PM EDT

DepoMed (NASDAQ: DEPO) reported Q1 EPS of ($0.13), $0.14 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $31.7 million versus the consensus estimate of $33.8 million.

DepoMed sees FY2015 revenue of $310-335 million, versus the consensus of $305.02 million.

For earnings history and earnings-related data on DepoMed (DEPO) click here.

... More